EMA's 'Successful' Adaptive Pathways Pilot To End, Concept Will Be Integrated Into Existing Frameworks
This article was originally published in SRA
Executive Summary
The European Medicines Agency's much vaunted pilot project on adaptive pathways for innovative medicines is to end and the scientific concept of iterative product development and data generation with use of real-life data that it enshrines is to be integrated into existing EU regulatory and health technology assessment (HTA) frameworks.